Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Circulation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 6133640
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pindolol: A New β-Adrenoceptor Antagonist with Partial Agonist Activity

  1983cited by this paper
• Role of beta-adrenergic blockade in the therapy of patients with myocardial infarction.

  1983cited by this paper
• Increased platelet aggregation in diabetes mellitus.

  1982cited by this paper
• Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists.

  1982cited by this paper
• Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.

  1982cited by this paper
• The Emerging Problem of Plasma Lipid Changes During Antihypertensive Therapy

  1982cited by this paper
• Effects of beta-adrenergic blockade on plasma lipids: A double-blind randomized placebo-controlled multi-center comparison of labetalol and metoprolol in patients with hypertension

  1982cited by this paper
• Coronary artery spasm: demonstration, definition, diagnosis, and consequences.

  1982cited by this paper
• Newer concepts in the pathophysiology of ischemic heart disease.

  1982cited by this paper
• Intrinsic sympathomimetic activity and coronary blood flow.

  1982cited by this paper
• Blood Flow Reductions in Stenosed Canine Coronary Arteries: Vasospasm or Platelet Aggregation?

  1982cited by this paper
• β-Adrenoceptor Antagonists: New Drugs and New Indications

  1981cited by this paper
• beta-Adrenoceptor antagonists: new drugs and new indications.

  1981cited by this paper
• Therapy of coronary vasoconstriction in patients with coronary artery disease.

  1981cited by this paper
• Nadolol: a new beta-adrenoceptor antagonist.

  1981cited by this paper
• EFFECT OF PROPRANOLOL AND PRAZOSIN ON BLOOD LIPIDS: The Oslo Study

  1980cited by this paper
• Myocardial infarct size. Part I. Basic considerations.

  1980cited by this paper
• Effect of propranolol and prazosin on blood lipids. The Oslo Study.

  1980cited by this paper
• The Role Of Platelets In Acute Vascular Events

  1980cited by this paper
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 12. Beta-adrenoceptor blockade in myocardial infarction: the continuing controversy.

  1980cited by this paper
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties.

  1979cited by this paper
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects.

  1979cited by this paper
• Role of blood platelets in coronary artery disease.

  1979cited by this paper
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: labetalol.

  1979cited by this paper
• STABILIZATION OF LYSOSOMES IN ANOXIC MYOCARDIUM BY PROPRANOLOL

  1979cited by this paper
• Increased Diastolic Time: A Possible Important Factor in the Beneficial Effect of Propranolol in Patients with Coronary Artery Disease

  1979cited by this paper
• Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.

  1979cited by this paper
• Abrupt propranolol withdrawal in angina pectoris: effects on platelet aggregation and exercise tolerance.

  1978cited by this paper
• Identification of α-Adrenergic Receptors in Human Platelets by [3H]Dihydroergocryptine Binding

  1978cited by this paper
• Segment stroke work and metabolism depend on coronary blood flow in the pig.

  1978cited by this paper
• Differences in platelet aggregation in coronary sinus and aortic blood in patients with coronary artery disease: Effect of propranolol

  1978cited by this paper
• Effects of a Cardiac Glycoside in Combination with Propranolol on the Ischemic Heart of Conscious Dogs

  1978cited by this paper
• The effect of established beta-adrenoreceptor-blocking therapy on the release of cytosolic and lysosomal enzymes after acute myocardial infarction in man.

  1978cited by this paper
• An evaluation of the coronary constriction following propranolol.

  1977cited by this paper
• Effect of propranolol on platelet function.

  1977cited by this paper
• The Effect of Propranolol on Microvascular Injury in Acute Myocardial Ischemia

  1977cited by this paper
• Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia.

  1977cited by this paper
• Altered hemoglobin-oxygen affinity with long-term propranolol therapy in patients with coronary artery disease.

  1977cited by this paper
• Myocardial ischemia (second of three parts).

  1977cited by this paper
• Myocardial ischemia (third of three parts).

  1977cited by this paper
• Myocardial ischemia (first of three parts).

  1977cited by this paper
• Distribution of coronary collateral flow in acute myocardial ischaemic injury: effect of propranolol.

  1976cited by this paper
• Propranolol-induced reduction of signs of ischemic injury during acute myocardial infarction.

  1976cited by this paper
• Platelet coagulant activities and serum lipids in transient cerebral ischemia.

  1976cited by this paper
• Regulation of coronary blood flow.

  1975cited by this paper
• Effect of Propranolol on Oxygen Binding to Hemoglobin In Vitro and In Vivo

  1974cited by this paper
• Platelet function in hyperlipoproteinemia.

  1974cited by this paper
• Propranolol in the Treatment of Acute Myocardial Infarction: Effect on Myocardial Oxygenation and Hemodynamics

  1974cited by this paper
• Reversal of Abnormal Platelet Aggregability and Change in Exercise Tolerance in Patients with Angina Pectoris Following Oral Propranolol

  1974cited by this paper
• Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion.

  1973cited by this paper
• Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.

  1973cited by this paper
• Effect of propranolol upon the hemoglobin-oxygen dissociation curve.

  1972cited by this paper
• Increased platelet aggregation in diabetes mellitus.

  1972cited by this paper
• Protection against epinephrine-induced myocardial necrosis by drugs that inhibit platelet aggregation.

  1972cited by this paper
• Oxygen Affinity in Red Cells: Changes Induced in vivo by Propranolol

  1972cited by this paper
• Myocardial energetics: basic principles and clinical implications.

  1971cited by this paper
• Effect of Ischemia and Antianginal Drugs on the Distribution of Radioactive Microspheres in the Canine Left Ventricle

  1971cited by this paper
• Movements of sodium and potassium ions and their tracers in propranolol-treated red cells and diaphragm muscle.

  1970cited by this paper
• Oxygen consumption of the heart. Newer concepts of its multifactoral determination.

  1968cited by this paper
• Increased platelet adhesiveness in hypertensive cardiovascular disease.

  1968cited by this paper
• Adenosine diphosphate-induced platelet aggregation and myocardial infarction in swine.

  1967cited by this paper
• REGULATION OF CORONARY BLOOD FLOW.

  1964cited by this paper
• A study of the adrenotropic receptors.

  1948cited by this paper

• Beta-Blockers after Myocardial Infarction in Patients without Heart Failure.

  2025cites this paper
• Differential Outcomes of Beta-Blockers According to Heart Rate Following Myocardial Infarction with Reduced Left Ventricular Ejection Fraction.

  2025cites this paper
• Early initiation of oral beta-blocker improves long-term survival in patients with acute myocardial infarction who underwent primary percutaneous coronary intervention

  2024cites this paper
• Antihypertensive and cardioprotective effects of three generations of beta-adrenergic blockers: an historical perspective

  2022cites this paper
• Long‐term impact of β‐blocker in elderly patients without myocardial infarction after percutaneous coronary intervention

  2021cites this paper
• Heterogeneous impact of hypotension on organ perfusion and outcomes: a narrative review.

  2021cites this paper
• The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study

  2018cites this paper
• Clinical considerations of drug management in chronic cardiovascular and respiratory disorders in perioperative healthcare

  2018cites this paper
• Are beta blockers still necessary for all survivors of acute myocardial infarction?

  2017cites this paper
• Role of Carvedilol in Prevention of Adrenaline Induced Myocardial Infraction in Experimental Animal

  2016cites this paper
• Accelerate and Decelerate in Primary Percutaneous Coronary Intervention.

  2016cites this paper
• Heart failure : biomarker effect and influence on quality of life

  2016cites this paper
• Selection of Medical Treatment in Stable Angina Pectoris: Results of the International Multicenter Angina Exercise (IMAGE) Study

  2016cites this paper
• Ser49Gly polymorphic markers associations of ADRB1 gene and 4a/4b eNOS gene with hypertension and ischemic heart disease among the population of mountain shoria natives

  2015cites this paper
• Angina treatments and prevention of cardiac events: an appraisal of the evidence.

  2015cites this paper
• Establishment and validation of a terminally differentiated adult rat ventricular cardiomyocyte model

  2014influential citation
• Therapy for triggered acute risk prevention in subjects at increased cardiovascular risk.

  2013cites this paper
• β-Adrenergic Blockade in Cardiovascular Disease

  2013cites this paper
• β-blocker use in patients after percutaneous coronary interventions: one size fits all? Worse outcomes in patients without myocardial infarction or heart failure.

  2013cites this paper
• Profile of an Ideal Antianginal Agent

  2012cites this paper
• Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®).

  2011cites this paper
• An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p.

  2010cites this paper
• Clinical Review: Is the Perioperative Use of β-Blockers Still Recommended? A Critical Review of Recent Controversies

  2009cites this paper
• Therapy for triggered acute risk prevention: a study of feasibility.

  2009cites this paper
• β-Adrenergic Blockers: A 50-Year Historical Perspective

  2008cites this paper
• RewCe Management of the Patient Following Coronary

  2008cites this paper
• Population Pharmacokinetic Data Analysis of Cilobradine, an If Channel Blocker

  2008cites this paper
• Acute coronary syndrome: Short-term effects of early intravenous metoprolol on maximum P wave duration and P wave dispersion

  2007cites this paper
• A Historical Perspective on the Development of β‐Adrenergic Blockers

  2007cites this paper
• [Expert Consensus document on beta-adrenergic receptor blockers].

  2005cites this paper
• Expert consensus document on b-adrenergic receptor blockers The Task Force on Beta-Blockers of the European Society of Cardiology Task Force Members , Jos

  2004cites this paper
• Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia

  2004cites this paper
• Expert consensus document on beta-adrenergic receptor blockers.

  2004cites this paper
• Beta-adrenergic blockers.

  2003cites this paper
• Drug therapy in chronic heart failure

  2003cites this paper
• Perioperative Use of Beta-Blockers: Past, Present, and Future

  2002influential citation
• Beta-adrenergic blockade during severe ischemia.

  2002cites this paper
• Clinical therapeutic conference: congestive heart failure therapy.

  2001cites this paper
• Comparison of Adenosine and Exercise Stress Test for Quantitative Perfusion Imaging in Patients on Beta-Blocker Therapy

  2001cites this paper
• Secondary prevention of myocardial infarction: role of beta-adrenergic blockers and angiotensin-converting enzyme inhibitors.

  1999cites this paper
• Effect of nitroglycerin and nicorandil on regional poststenotic quantitative coronary blood flow in coronary artery disease: a combined digital quantitative angiographic and intracoronary doppler study.

  1999cites this paper
• [Kinetic analysis of therapeutic doses of beta-blockers for angina pectoris based on receptor occupancy theory--relationship between beta 1-receptor occupancy or vasodilative action and dose].

  1999cites this paper
• Pharmacokinetic‐pharmacodynamic modeling of the effects of ivabradine, a direct sinus node inhibitor, on heart rate in healthy volunteers

  1998cites this paper
• Pharmacokinetics and pharmacodynamics of propranolol in hypertensive patients after sublingual administration: systemic availability.

  1998cites this paper
• Beta-Adrenergic Blockade Decreases Coronary Collateral Blood Flow in Patients with Coronary Artery Disease

  1998cites this paper
• Antianginal effects of YM430, a novel calcium entry-blocking and beta-adrenoceptor-blocking agent in several experimental angina models.

  1997cites this paper
• Effect of beta 1 adrenergic receptor blockade on myocardial blood flow and vasodilatory capacity.

  1997cites this paper
• Failure of allopurinol to improve left ventricular stroke work after cardiopulmonary bypass surgery.

  1996cites this paper
• Heart rate reduction in the treatment of chronic stable angina pectoris: experiences with a sinus node inhibitor.

  1996cites this paper
• Selection of medical treatment in stable angina pectoris: results of the International Multicenter Angina Exercise (IMAGE) Study.

  1995cites this paper
• Addition of zatebradine, a direct sinus node inhibitor, provides no greater exercise tolerance benefit in patients with angina taking extended-release nifedipine: results of a multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The Zatebradine Study Group.

  1995cites this paper
• From antianginal drugs to myocardial cytoprotective agents.

  1995cites this paper
• Chronobiology and chronotherapy in medicine.

  1995cites this paper
• Early intravenous administration of metoprolol enhances myocardial salvage by thrombolysis with recombinant tissue-type plasminogen activator after thrombotic coronary artery occlusion in the dog by improvement of the collateral blood flow to the area at risk.

  1994cites this paper
• Effects of oral pretreatment with metoprolol on left ventricular wall motion, infarct size, hemodynamics, and regional myocardial blood flow in anesthetized dogs during thrombotic coronary artery occlusion and reperfusion

  1994cites this paper
• Intravenous Metoprolol Preceding Thrombolysis in Acute Thrombotic Myocardial Infarction in the Dog; Effects on Infarct Size, Myocardial Blood Flow, and Left Ventricular Function

  1994cites this paper
• Lack of effect of propranolol on canine coronary collateral development during progressive coronary stenosis and occlusion.

  1993cites this paper
• Prediction of therapeutic doses of beta-adrenergic receptor blocking agents based on quantitative structure-pharmacokinetic/pharmacodynamic relationship.

  1993cites this paper
• Development of a multiaction beta blocker. Scientific challenges and regulatory needs.

  1993cites this paper
• Silent myocardial ischemia monitoring predicts late as well as perioperative cardiac events in patients undergoing vascular surgery.

  1992cites this paper
• Management of acute myocardial infarction in the very elderly.

  1992cites this paper
• SPECIAL PROBLEMS REGARDING ALLERGEN IMMUNOTHERAPY

  1992cites this paper
• Comparative efficacy and concomitant use of bepridil and beta blockers in the management of angina pectoris.

  1992cites this paper
• Beta-adrenergic blockers as cardioprotective agents.

  1992cites this paper
• Attenuation of myocardial ischemia during coronary occlusion by ultrashort-acting beta adrenergic blockade.

  1991cites this paper
• Ultra short-acting intravenous beta-adrenergic blockade as add-on therapy in acute unstable angina.

  1991cites this paper
• The deficiencies of current medical therapy for the management of angina pectoris.

  1991cites this paper
• Circadian variations in myocardial ischemia. Implications for management.

  1991cites this paper
• Inhibition of Dipyridamole‐Induced Ischemia by Antianginal Therapy in Humans: Correlation With Exercise Electrocardiography

  1991cites this paper
• Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.

  1991cites this paper
• Management of the patient following coronary thrombolysis

  1990cites this paper
• Reduction of mortality, sudden death and non-fatal reinfarction with beta-adrenergic blockers in survivors of acute myocardial infarction: a new hypothesis regarding the cardioprotective action of beta-adrenergic blockade.

  1990cites this paper
• Relations Between Heart Rate, Ischemia, and Drug Therapy During Daily Life in Patients With Coronary Artery Disease

  1990cites this paper
• Acute Effects of Nisoldipine, Propranolol, and Their Combination in Patients with Chronic Stable Angina: A Double‐Blind, Randomized, Cross‐Over, Placebo‐Controlled Study

  1990cites this paper
• Circadian influence in cardiovascular disease (Part 1).

  1990cites this paper
• Chronic beta-blocker therapy complicating the presentation of cardiac tamponade of malignancy.

  1989cites this paper
• Beta-blockers in chronic treatment after acute myocardial infarction.

  1989cites this paper
• Nitrous oxide does not induce myocardial ischemia in patients with ischemic heart disease and poor ventricular function.

  1989cites this paper
• Morning increase of onset of myocardial infarction. Implications concerning triggering events.

  1989cites this paper
• Interaction between the release of adenosine and noradrenaline during sympathetic stimulation: a feed-back mechanism in rat heart.

  1989cites this paper
• Beta-adrenergic blockade and calcium channel blockade in myocardial infarction.

  1989cites this paper
• The Use of β‐Blockers in Unstable Angina: Comparison with Calcium Channel Blocking Agents

  1988cites this paper
• Safety and efficacy of esmolol for unstable angina pectoris.

  1988cites this paper
• Risk of anaphylaxis in patients receiving beta-blocker drugs.

  1988cites this paper
• Antianginal drug therapy for silent myocardial ischemia.

  1987cites this paper
• Clinical Management of Asymptomatic Myocardial Ischemia

  1987cites this paper
• Antianginal drug therapy for silent myocardial ischemia.

  1987cites this paper
• Choice of therapy in angina.

  1987cites this paper
• Efficacy of nisoldipine combined with beta‐adrenergic‐blocking drugs in the treatment of chronic stable angina

  1987cites this paper
• Beta-blocker therapy and the risk of anaphylaxis.

  1987cites this paper
• Calcium-channel blockers for combined angina pectoris and systemic hypertension.

  1986cites this paper
• Management of a patient recovering from myocardial infarction: a decision tree.

  1986cites this paper
• Metoprolol, nifedipine, and the combination in stable effort angina pectoris.

  1986cites this paper
• Prognostic factors in acute pulmonary edema.

  1986cites this paper
• Beta blocking agents in post myocardial infarction patients.

  1986cites this paper
• Beta adrenergic receptor blockade of feline myocardium. Cardiac mechanics, energetics, and beta adrenoceptor regulation.

  1986cites this paper
• Cardioprotective effects of defibrotide in acute lethal and nonlethal myocardial ischemia in the cat.

  1986cites this paper
• Effect of beta1 selective adrenoceptor blockade on physiological response to exercise.

  1985cites this paper
• Combination propranolol and bepridil therapy in stable angina pectoris.

  1985cites this paper
• Effect of selective and nonselective beta-adrenoceptor blockade on thermoregulation during prolonged exercise in heat.

  1985cites this paper